Advertisement

U.S. markets open in 7 hours 10 minutes

S&P Futures
4,268.50
-8.25(-0.19%)
Dow Futures
33,921.00
-42.00(-0.12%)
Nasdaq Futures
13,459.25
-34.00(-0.25%)
Russell 2000 Futures
1,987.90
-1.20(-0.06%)
Crude Oil
88.16
+0.05(+0.06%)
Gold
1,777.00
+0.30(+0.02%)

Advertisement

Savara Inc. (SVRA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

1.6300

-0.0200

(-1.21%)

At close: 04:00PM EDT

1.6043

-0.03

(-1.58%)

After hours:

05:03PM EDT

Advertisement

Loading interactive chart...

Business Wire
Savara Reports Second Quarter 2022 Financial Results and Provides Business Update
AUSTIN, Texas, August 11, 2022--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the second quarter ending June 30, 2022 and provided a business update.
Simply Wall St.
What Kind Of Investors Own Most Of Savara Inc. (NASDAQ:SVRA)?
If you want to know who really controls Savara Inc. ( NASDAQ:SVRA ), then you'll have to look at the makeup of its...
Business Wire
Savara Announces Acceptance of Three Abstracts at the European Respiratory Society (ERS) International Congress 2022
AUSTIN, Texas, July 11, 2022--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the acceptance of three abstracts for poster presentation at the ERS International Congress 2022 to be held in-person and virtually, September 4-6, 2022 in Barcelona, Spain.